SCHEMBL7689953

SCHEMBL7689953

O=C(NCC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1-c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.52
CHRNB4 P30926 1/20 0.52
CHRNA3 P32297 1/20 0.52
CHRNA4 P43681 1/20 0.52
ACE P12821 5/20 0.50
TACR2 P21452 1/20 0.50
CAPN1 P07384 1/20 0.48
CTSL P07711 4/20 0.48
CTSS P25774 3/20 0.48
CTSK P43235 3/20 0.48
CTSB P07858 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ACE2 Q9BYF1 2/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
HPGDS O60760 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698402 0.88 CHRNB2 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL7659419 0.82 NAAA (0.44) CHRNB2CHRNB4CHRNA3CHRNA4CAPN1
SCHEMBL7694147 0.81 ACE (0.46) ACECTSLCTSSCTSKL3MBTL1
SCHEMBL7695358 0.81 CHRNB2 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL7690558 0.81 CAPN1 (0.60) ACECAPN1CTSLCTSSCTSK
SCHEMBL7704469 0.80 KCNA5 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL3641713 0.79 CAPN1 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL3642696 0.79 CAPN1 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL3642692 0.79 CAPN1 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4TACR2
SCHEMBL7381726 0.78 BACE1 (0.58) CHRNB2CHRNB4CHRNA3CHRNA4TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed